Atlas Trials

Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use

Clinical trial NCT00221299 · COMPLETED

Trial details

NCT number
NCT00221299
Sponsor
University of California, Davis
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Osteoporosis
Start date
2005-09-01
Primary completion
2009-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.